Find investors
← Back to all investors
Fabrice Georget
ResearchedAngel Investors

Fabrice Georget

Partner

Angel InvestorsSeed Round
Pitch Fabrice

Get their honest, personalized take on your startup.

Sign in to pitch Fabrice

At a glance

Full Name
Fabrice Georget
Title
Partner
Firm
Charterhouse Capital Partners LLP
Firm Type
Private equity / European mid-market buyout firm
Investment Stage
Mid-market buyouts and private equity growth/partnership investments
Check Size
Charterhouse targets transactions of approximately €150m-€1.5bn
Target Company Profile
High-quality European mid-market companies, typically established businesses where Charterhouse can partner with management teams on growth, buy-and-build, internationalisation, operational improvement, digitalisation, or strategic repositioning
Sector Focus
Healthcare and Services at firm level; Fabrice has been involved in transactions across healthcare, business services, consumer, financial software, telecom/connected devices, engineering, retail, insurance brokerage, and infrastructure
Geographic Focus
Europe, with Fabrice's Charterhouse regional focus listed as France
Location
London, United Kingdom

Background

Fabrice Georget is a Partner in Charterhouse Capital Partners' Deal Team and sits on the firm's Investment Committee. He joined Charterhouse in 2005 and has been involved in transactions including Avent, Cooper, Epolia, Fives, Nocibé, Sagemcom, Siaci Saint Honoré, TDF, Vermeg, and Labomar.

Before Charterhouse, Georget spent three years with CDC Equity Capital in Paris. Earlier in his career, he spent six years at Andersen as a consultant specialising in transaction services and turnaround situations.

His education spans law and finance: Charterhouse states that he has a degree in Business Law from Paris Panthéon Assas University and a degree in Finance from Paris Dauphine University. LinkedIn also lists Université Paris Dauphine - PSL from 1993 to 1995. He is fluent in French and English.

Investment Thesis & Focus

  • Charterhouse describes its strategy as "Committed to European mid-market buyouts" and positions itself as a "Lead investor in European mid-market private equity investments."
  • The firm's target transaction size is €150m-€1.5bn, so Georget is not a seed-stage angel investor based on verified sources.
  • Charterhouse focuses on Europe, specifically UK & Ireland, France & Benelux, Southern Europe, and DACH; Georget's own regional focus is France.
  • At firm level, Charterhouse currently states its target sectors as Services and Healthcare.
  • The firm looks for situations where it can partner with management teams and support long-term value creation through operational improvement, strategic repositioning, digitalisation, internationalisation, and buy-and-build M&A.
  • Georget's transaction history suggests particular relevance for French or France-linked healthcare, services, insurance brokerage, financial software, telecom/connected-device, infrastructure, consumer, and industrial companies.

Notable Investments

  • Sagemcom - French-headquartered provider of connected terminals and software for communications, entertainment, and utilities; Charterhouse invested in 2016, and Georget was quoted at announcement saying Charterhouse was backing growth in connected devices, UHD broadcasts, and smart utility meters.
  • Cooper Consumer Health - Paris-headquartered OTC drug manufacturer and distributor; Charterhouse invested in 2016, later agreed a majority sale to CVC in 2021 while making a significant reinvestment.
  • Siaci Saint Honoré - French global insurance brokerage, advisory, and claims-management business; Charterhouse acquired a majority stake in 2018 and entered exclusive negotiations to sell in 2021, with Georget quoted on the company's growth journey and insurance-broking leadership.
  • Vermeg - Financial-services software and digitalisation provider; Charterhouse invested in December 2020 alongside the founder and management team, backing organic growth and M&A in financial software.
  • Labomar - Italian B2B CDMO for nutraceuticals, medical devices, and food supplements; Charterhouse invested in 2023, partnering with founder Walter Bertin after Labomar's delisting.
  • Fives Group - French global engineering company; Charterhouse entered in 2006 and sold to AXA Private Equity in 2012 after supporting acquisitions, emerging-market expansion, R&D, and new technologies.
  • Nocibé - French specialist perfume and cosmetics retailer; Charterhouse entered in 2006 and sold to Advent International in 2014 after expanding the store network and online offering.
  • TDF - French broadcast-tower operator; Charterhouse originally acquired TDF in 2002, retained a minority stake after selling majority control to TPG in 2007, and exited in 2016.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.